Win a fitness package worth more than £3,000
Cloning research “clearly upsets the general public” yet it has limited potential for treating disease and adds little to scientific understanding of human biology, according to Professor Austin Smith of the University of Cambridge.
While it is in theory possible that cloned embryonic stem (ES) cells could be used to create patient-matched tissue for treating disease, significant technical barriers mean that this goal may never be realised in practice, he told The Times.
Research with ordinary stem cells taken from surplus IVF embryos and adult tissue is less controversial and more likely to lead to medical benefits, but has been given much less public attention.
The hype surrounding cloning has encouraged the mistaken view that it is essential to all stem-cell work, and left the whole field tarnished by the scandal surrounding Woo-Suk Hwang, the disgraced Korean scientist who faked his cloning research.
While some cloning experiments proceed for the sake of intellectual curiosity, the research community should be much clearer about the limitations, Professor Smith said. “Its prominence is out of proportion to the significance of what’s being done, and there are real question marks about whether it has any utility at all,” he said.
Professor Smith would prefer scientists to focus on basic understanding of ES cells and adult stem cells, both of which will be studied in depth at the Wellcome Trust Centre for Stem Cell Research in Cambridge, which officially opens today. He recently moved from the University of Edinburgh to become its first director.
Professor Smith was also critical of efforts to devise new ways of collecting ES cells without destroying human embryos, which some scientists have promoted as “more ethical” sources of the tissue. These eye-catching experiments actually play into the hands of embryo-rights groups who will always object to ES cell research, by suggesting that scientists are uncomfortable with the ethics of existing techniques.

Life's been a blast for the baby boomers but how does it really feel now that they are 60? Two writers square off
Industry sectors news at a glance. Interactive heatmap, video and podcast
The inside track on current trends in the charity, not for profit and social enterprise sectors
Read our exclusive 100 Years of Fleming and Bond interactive timeline, packed with original Times articles and reviews
Everything the Business Traveller needs to know to make a better trip
Shortcuts to help you find sections and articles
05/2005
£13,500
08/2008
£109,950
2006
£10,750
Great car insurance deals online
£Excellent+ executive benefits
Torres and Partners
London
£49,229 - £62,035 pro rata
Charity Commission
London/Liverpool/Taunton
Alstom Power
Europe
Six Figure
Rolls Royce
Midlands/Europe
From £89,950
Great Investment, River Views
Special Offers now available
At the new sophisticated
Encore Las Vegas Resort!
Cruise the Islands of Hawaii - Pride of America
List your property with two leading travel websites
Great travel insurance deals online
Contact our advertising team for advertising and sponsorship in Times Online, The Times and The Sunday Times, or place your advertisement.
Times Online Services: Dating | Jobs | Property Search | Used Cars | Holidays | Births, Marriages, Deaths
News International associated websites: Globrix | Property Finder | Milkround
Copyright 2008 Times Newspapers Ltd.
This service is provided on Times Newspapers' standard Terms and Conditions. Please read our Privacy Policy.To inquire about a licence to reproduce material from Times Online, The Times or The Sunday Times, click here.This website is published by a member of the News International Group. News International Limited, 1 Virginia St, London E98 1XY, is the holding company for the News International group and is registered in England No 81701. VAT number GB 243 8054 69.